These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7644626)

  • 1. Bosentan, an orally active endothelin antagonist: effect on the renal response to contrast media.
    Oldroyd SD; Haylor JL; Morcos SK
    Radiology; 1995 Sep; 196(3):661-5. PubMed ID: 7644626
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of adenosine receptor antagonists on the responses to contrast media in the isolated rat kidney.
    Oldroyd SD; Fang L; Haylor JL; Yates MS; El Nahas AM; Morcos SK
    Clin Sci (Lond); 2000 Mar; 98(3):303-11. PubMed ID: 10677389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role for endothelin in the renal responses to radiocontrast media in the rat.
    Oldroyd S; Slee SJ; Haylor J; Morcos SK; Wilson C
    Clin Sci (Lond); 1994 Oct; 87(4):427-34. PubMed ID: 7834995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The acute effect of ioversol on kidney function: role of endothelin.
    Oldroyd SD; Haylor JL; Morcos SK
    Eur J Radiol; 1995 Jan; 19(2):91-5. PubMed ID: 7713094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new animal model for testing renal tolerance of contrast agents.
    Krause W; Gilles T
    Invest Radiol; 2003 Nov; 38(11):704-11. PubMed ID: 14566180
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of endothelin receptor subtypes in the rat kidney. Renal and haemodynamic effects of the mixed (A/B) endothelin receptor antagonist bosentan.
    Hocher B; Rohmeiss P; Diekmann F; Zart R; Vogt V; Schiller S; Bauer C; Koppenhagen K; Distler A; Gretz N
    Eur J Clin Chem Clin Biochem; 1995 Aug; 33(8):463-72. PubMed ID: 8547428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reduced depression of renal function by iotrolan in the isolated rat kidney.
    Oldroyd S; Haylor J; Morcos SK; el Nahas AM
    Eur J Radiol; 1994 Feb; 18(1):64-9. PubMed ID: 8168587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bosentan normalizes the GFR response to renal nerve stimulation following reversible unilateral ureteric obstruction in the rat.
    Hammad FT; Wheatley AM; Davis G
    Physiol Res; 2014; 63(6):713-22. PubMed ID: 25157662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of endothelin receptors attenuates end-organ damage in homozygous hypertensive ren-2 transgenic rats.
    Dvorák P; Kramer HJ; Bäcker A; Malý J; Kopkan L; Vanecková I; Vernerová Z; Opocenský M; Tesar V; Bader M; Ganten D; Janda J; Cervenka L
    Kidney Blood Press Res; 2004; 27(4):248-58. PubMed ID: 15286437
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of diatrizoate on the function of the isolated perfused rat kidney.
    Brown P; Haylor J; Morcos SK; Cope GH; el Nahas AM
    Br J Radiol; 1992 Nov; 65(779):1011-7. PubMed ID: 1450815
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics and pharmacodynamics of the endothelin-receptor antagonist bosentan in healthy human subjects.
    Weber C; Schmitt R; Birnboeck H; Hopfgartner G; van Marle SP; Peeters PA; Jonkman JH; Jones CR
    Clin Pharmacol Ther; 1996 Aug; 60(2):124-37. PubMed ID: 8823230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between the diuretic effect of radiocontrast media and their ability to increase renal vascular resistance.
    Morcos SK; Brown PW; Oldroyd S; el Nahas AM; Haylor J
    Br J Radiol; 1995 Aug; 68(812):850-3. PubMed ID: 7551782
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelin antagonists in salt-dependent hypertension associated with renal insufficiency.
    Doucet J; Gonzalez W; Michel JB
    J Cardiovasc Pharmacol; 1996 May; 27(5):643-51. PubMed ID: 8859933
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of nonsteroidal anti-inflammatory drugs on rat gastric mucosa. The role of endothelin.
    Murat N; Gidener S; Koyuncuoglu M; Yilmaz O
    Saudi Med J; 2007 Apr; 28(4):612-6. PubMed ID: 17457488
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacological characterization of bosentan, a new potent orally active nonpeptide endothelin receptor antagonist.
    Clozel M; Breu V; Gray GA; Kalina B; Löffler BM; Burri K; Cassal JM; Hirth G; Müller M; Neidhart W
    J Pharmacol Exp Ther; 1994 Jul; 270(1):228-35. PubMed ID: 8035319
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endothelin receptor antagonist combined with a calcium channel blocker attenuates renal injury in spontaneous hypertensive rats with diabetes.
    Chen J; Gu Y; Lin F; Yang H; Zhu W; Ma J; Lin S
    Chin Med J (Engl); 2002 Jul; 115(7):972-8. PubMed ID: 12150723
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Renal endothelin system in polycystic kidney disease.
    Hocher B; Zart R; Schwarz A; Vogt V; Braun C; Thöne-Reineke C; Braun N; Neumayer HH; Koppenhagen K; Bauer C; Rohmeiss P
    J Am Soc Nephrol; 1998 Jul; 9(7):1169-77. PubMed ID: 9644626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of an endothelin-receptor antagonist, bosentan, on blood pressure in patients with essential hypertension. Bosentan Hypertension Investigators.
    Krum H; Viskoper RJ; Lacourciere Y; Budde M; Charlon V
    N Engl J Med; 1998 Mar; 338(12):784-90. PubMed ID: 9504938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of renal denervation on renal effects of acute nitric oxide and ETA/ETB receptor inhibition in conscious normotensive rats.
    Girchev R; Markova P; Vuchidolova V
    J Physiol Pharmacol; 2006 Mar; 57(1):17-27. PubMed ID: 16601312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of endothelin in FK506-induced vascular reactivity changes in rat perfused kidney.
    Tekes E; Soydan G; Tuncer M
    Eur J Pharmacol; 2005 Jul; 517(1-2):92-6. PubMed ID: 15964565
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.